Raman Bahal is an Associate Professor at the Department of Pharmaceutical Sciences at the University of Connecticut. He received PhD at Carnegie Mellon and postdoctoral training at Yale and worked on a gene targeting project for treating hematological disorders and cancer. His lab is developing new therapeutic modalities for targeting genomic DNA and RNA at the interface of nucleic acid chemistry and its delivery strategies. Raman has published 70 research papers, including those in prestigious journals like Nature, Nature Communications, Science Advances, and Cell Report Medicine. He received the American Association of University Professors (AAUP), Excellence in Research & Creativity: Early Career Award (2021), National Institute of Pharmaceutical Technology and Education (NIPTE) Rising Star Scholarship Award (2021), American Association of Pharmaceutical Scientists (AAPS), Emerging Leader Award (2023), Oligonucleotide Therapeutic Society (OTS), Young Investigator Award (2023), RNA Society, Moderna Award for Biomedical Innovation in RNA (2024) and various teaching awards. He was selected as a senior member of the National Academy of Inventors. He also received various intramural and extramural funding from St. Baldrick Foundation Research Scholar Grant, the Charles H. Hood Foundation Grant, Cooley’s Anemia Foundation, the American Cancer Society Research Scholar Award, and several NIH grants.
Disclosure information not submitted.
Keynote: Development of Oligonucleotide Therapeutics
Wednesday, May 15, 2024
1:00 PM – 2:00 PM PT